Title Associate Professor of Radiology Institution Massachusetts General Hospital Address Massachusetts General Hospital White 427 55 Fruit St Boston MA 02114
|
|
Overview
Research
The research activities and funding listed below are automatically derived from
NIH ExPORTER and other sources, which might result in incorrect or missing items.
Faculty can
login
to make corrections and additions.
-
S10OD034326
(LIANG, STEVEN H)
May 15, 2024 - May 14, 2025
micro-PET/CT system for preclinical molecular imaging
Role: Principal Investigator
-
R01AG083084
(LIANG, STEVEN H)
Sep 1, 2023 - May 31, 2028
Translation of GluN2B-selective PET radiopharmaceuticals in Alzheimers patients
Role: Principal Investigator
-
RF1AG081401
(LIANG, STEVEN H)
May 1, 2023 - Apr 30, 2026
Glycogen synthase kinase 3 ligand discovery for Alzheimer’s disease
Role: Principal Investigator
-
R61NS130128
(LIANG, STEVEN H)
Apr 15, 2023 - Mar 31, 2026
Subtype-Selective Metabotropic Glutamate Receptor PET Ligands
Role: Principal Investigator
-
R01AG079956
(LIANG, STEVEN H)
Jan 1, 2023 - Nov 30, 2027
Subtype-selective phosphodiesterase PET ligands
Role: Principal Investigator
-
R21AG080262
(LIANG, STEVEN H)
Dec 1, 2022 - Nov 30, 2024
PET imaging of ionotropic glutamate receptor signaling in Alzheimer's disease
Role: Principal Investigator
-
R01MH128705
(LIANG, STEVEN H)
Jun 10, 2022 - Apr 30, 2027
PET ligand discovery for arginine vasopressin
Role: Principal Investigator
-
R01AG075444
(LIANG, STEVEN H)
Apr 1, 2022 - Mar 31, 2027
Subtype-selective NMDA ligands for Alzheimer's Disease
Role: Principal Investigator
-
R01AG073428
(LIANG, STEVEN H)
Sep 1, 2021 - Aug 31, 2026
AMPAR ligand discovery for Alzheimer's disease
Role: Principal Investigator
-
RF1AG073428
(LIANG, STEVEN HUAN)
Sep 1, 2021 - Aug 31, 2024
AMPAR ligand discovery for Alzheimer's disease
Role: Principal Investigator
-
R21AG074218
(LIANG, STEVEN H)
Sep 1, 2021 - Jun 30, 2024
PET Imaging for neuroinflammation in Alzheimer's disease
Role: Principal Investigator
-
R01AG070060
(LIANG, STEVEN H)
Jan 1, 2021 - Dec 31, 2025
Ligand discovery for delineating cholesterol homeostasis in the brain
Role: Principal Investigator
-
R03AG063290
(LIANG, STEVEN HUAN)
Sep 1, 2019 - May 31, 2021
MAGL PET tracer-guided prognosis and neuroprotective therapy for Alzheimer's disease
Role: Principal Investigator
-
R01MH120197
(LIANG, STEVEN HUAN)
Jun 21, 2019 - Mar 31, 2022
In vivo Probe for ionotropic glutamate signaling system: AMPA receptors
Role: Principal Investigator
-
R01MH117125
(LIANG, STEVEN HUAN)
Jul 1, 2018 - Mar 31, 2021
PET ligand development for mGlu2 based on negative allosteric modulators
Role: Principal Investigator
-
R33DA043507
(LIANG, STEVEN HUAN)
Jul 1, 2017 - Jun 30, 2022
Novel PET Tracers for Imaging Monoacylglycerol Lipase in Endocannabinoid Signaling
Role: Principal Investigator
-
R21DA043507
(LIANG, STEVEN HUAN)
Jul 1, 2017 - Jun 30, 2019
Novel PET Tracers for Imaging Monoacylglycerol Lipase in Endocannabinoid Signaling
Role: Principal Investigator
-
K01DA038000
(LIANG, STEVEN HUAN)
Jul 1, 2014 - Jun 30, 2019
New PET tracers for neuroimaging of FAAH in endocannabinoid signaling
Role: Principal Investigator
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.